Open AccessElevations in Serum and Urinary Calcium with Parathyroid Hormone (1-84) with and without Alendronate for Osteoporosis
Author(s) -
Diana M. Antoniucci,
Deborah E. Sellmeyer,
John P. Bilezikian,
Lisa Palermo,
Kristine E. Ensrud,
Susan L. Greenspan,
Dennis M. Black
Publication year - 2006
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-1788
Subject(s) - urinary calcium , medicine , endocrinology , hypercalciuria , liter , calcium , parathyroid hormone , confidence interval , discontinuation , vitamin d and neurology , hazard ratio , urinary system , urology , gastroenterology
The effect of PTH therapy on serum and urinary calcium levels and the risk of hypercalcemia or hypercalciuria has not been formally evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom